drugset / Trial / NCT00347360
The COREG And Lisinopril Combination Therapy In Hypertensive Subjects (COSMOS) Trial
RandomizedParallel-groupDouble-blindTreatment
Summary
This is a randomized, double-blind, double-dummy, parallel group trial employing 15 cells of a 4x4 factorial design (no placebo)to compare the hypertensive effects in patients with Stage 1 and Stage 2 hypertension of carvedilol (20, 40 or 80 mg daily) alone, lisinopril (10, 20 or 40 mg daily) alone, and all combinations of the doses.
Timeline
- Start
- 2006-07
- Primary completion
- 2008-04
- Completion
- 2008-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Carvedilol | Other / unclassified | 20 mg | — |
| Subject | Carvedilol | Other / unclassified | 40 mg | — |
| Subject | Carvedilol | Other / unclassified | 80 mg | — |
| Subject | LISINOPRIL ANHYDROUS | Small molecule | 10 mg | — |
| Subject | LISINOPRIL ANHYDROUS | Small molecule | 20 mg | — |
| Subject | LISINOPRIL ANHYDROUS | Small molecule | 40 mg | — |